Nasdaq

Tactile Medical Presents Promising Clinical Data for Flexitouch Plus in Treating Head and Neck Cancer-Related Lymphedema at ASCO 2025 Annual Meeting

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...
Seeking Alpha

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
Business Insider

Tactile Medical Announces New Clinical Publication Assessing the Use of Flexitouch for the Treatment of Head & Neck Lymphedema

MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment ...
Nasdaq

Tactile Medical Stock Rises After Positive Flexitouch Trial Results

Tactile Systems Technology, Inc. (TCMD), popularly known as Tactile Medical, has announced positive results from the clinical study evaluating Flexitouch advanced pneumatic compression device (APCD) ...